EFFICACY OF GOSERELIN FOR POST-OPERATIVE TREATMENT IN CHINESE PATIENTS WITH MODERATE TO SEVERE ENDOMETRIOSIS: AN OBSERVATIONAL, MULTICENTRE, OPEN-LABEL, NON-INTERVENTIONAL STUDY
Abstract
Â
Objective: The aim was to assess the efficacy of post-operative adjuvant treatment with goserelin acetate for reducing the recurrence of pelvic
symptoms and total recurrence rates in Chinese patients with moderate to severe endometriosis.
Methods: This largest non-interventional, observational study enrolled 426 Chinese patients with moderate to severe endometriosis across 15 centers
in China. Goserelin acetate depot (3.6 mg) was prescribed as adjuvant post-operative treatment, subcutaneously every 4 weeks till 18 months. The
primary efficacy end-point was improvement of pelvic symptom recurrence rate and total recurrence rates (including pelvic symptom and physical
findings) up to 18 months post-surgery. Secondary endpoints were pregnancy rate among infertile subjects receiving post-operative goserelin
treatment 18 months following the operation; and information on goserelin administration.
Results: The total recurrence rate (8.2%; 95% confidence interval [CI], 5.8-11.3%) and symptom recurrence rate (5.6%; 95% CI, 3.6-8.2%) in Chinese
patients with moderate to severe endometriosis was comparatively lower than the previously reported studies. Less than 28% of the patients required
add-back therapy to offset the effects of gonadotropin-releasing hormone (GnRH), and indicated that the GnRH agonist was efficacious in the majority
of the patients. No serious adverse events were reported during the study.
Conclusion: Goserelin acetate was effective in reducing symptom and total recurrence rate when used post-operatively in Chinese patients with
mild to severe endometriosis. The authors therefore offered goserelin acetate as a viable treatment for Chinese patients with moderate to severe
endometriosis.
Keywords: Endometriosis, Gonadotropin-releasing hormone, Goserelin acetate, Pelvic symptom recurrence rate, Infertility, Pregnancy rate.
Downloads
References
Ozawa Y, Murakami T, Terada Y, Yaegashi N, Okamura K, Kuriyama S, et al. Management of the pain associated with endometriosis: an update of the painful problems. Tohoku J Exp Med 2006;210(3):175-88.2. Crosignani PG, Vercellini P. Conservative surgery for severe endometriosis: should laparotomy be abandoned definitively? Hum Reprod 1995;10(9):2412-8.
Crosignani PG, Vercellini P, Biffignandi F, Costantini W, Cortesi I, Imparato E. Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis. Fertil Steril 1996;66(5):706-11.
Bergqvist A, Bergh T, Hogström L, Mattsson S, Nordenskjöld F, Rasmussen C. Effects of triptorelin versus placebo on the symptoms of endometriosis. Fertil Steril 1998;69(4):702-8.
Vercellini P, Crosignani PG, Fadini R, Radici E, Belloni C, Sismondi P. A gonadotrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 1999;106(7):672-7.
Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988;318(8):485-9.
Telimaa S, Apter D, Reinilä M, Rönnberg L, Kauppila A. Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate. Eur J Obstet Gynecol Reprod Biol 1990;36(1-2):97-105.
Winkel CA. Evaluation and management of women with endometriosis. Obstet Gynecol 2003;102(2):397-408.
Reichel RP, Schweppe KW. Goserelin (Zoladex) depot in the treatment of endometriosis. Zoladex Endometriosis Study Group. Fertil Steril 1992;57(6):1197-202.
Shaw RW. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Fertil Steril 1992;58:265-72.
Rock JA, Truglia JA, Caplan RJ. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. Obstet Gynecol 1993;82(2):198-205.
Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005;20(10):2698-704.
Lang J. The guideline of diagnosis and treatment of endometriosis. Chin J Obstet Gynecol 2007;42:645-8.
Busacca M, Somigliana E, Bianchi S, De Marinis S, Calia C, Candiani M, et al. Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III-IV: a randomized controlled trial. Hum Reprod 2001;16(11):2399-402.
Zhou Y. The guideline of diagnosis and treatment of endometriosis. Prog Obstet Gynecol 2006;15:161-72.
Xiong Y, Zhu B, Ling Y. The guideline of diagnosis and treatment of endometriosis. Prog Obstet Gynecol 2005;14:492-4.
Shen X, Feng Z. The efficacy of laparoscopy in combination with medical treatment on endometriosis. Jiangxi Pharmacol 2006;42:586-8.
Loverro G, Carriero C, Rossi AC, Putignano G, Nicolardi V, Selvaggi L. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis. Eur J Obstet Gynecol Reprod Biol 2008;136(2):194-8.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.